Preclinical studies of experimental MS therapy GV300 showed reduced disease severity and spinal cord inflammation in mice.
#MultipleSclerosis #MS
Preclinical studies of experimental MS therapy GV300 showed reduced disease severity and spinal cord inflammation in mice.
#MultipleSclerosis #MS